Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
Ottaiano A, Mollo E, Di Lorenzo G, Pisano C, Di Maio M, Barletta E, Pensabene M, Segati R, Bullian P, Nasti G, Bryce J, Scala S, Castello G, Ascierto PA. Ottaiano A, et al. Among authors: di lorenzo g, di maio m. Cancer Immunol Immunother. 2005 Jan;54(1):44-50. doi: 10.1007/s00262-004-0567-z. Cancer Immunol Immunother. 2005. PMID: 15693138 Free PMC article. Review.
Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?
Gómez Rivas J, Carrion DM, Alvarez-Maestro M, Cathelineau X, Sanchez-Salas R, Di Lorenzo G, Di Maio M, Paul A, Martinez-Piñeiro L, Sartor O, Saad F, Debruyne F. Gómez Rivas J, et al. Among authors: di lorenzo g, di maio m. Minerva Urol Nefrol. 2019 Oct;71(5):445-456. doi: 10.23736/S0393-2249.19.03420-9. Epub 2019 Jul 25. Minerva Urol Nefrol. 2019. PMID: 31353876 Free article. Review.
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer.
D' Alterio C, Portella L, Ottaiano A, Rizzo M, Carteni G, Pignata S, Facchini G, Perdona S, Di Lorenzo G, Autorino R, Franco R, La Mura A, Nappi O, Castello G, Scala S. D' Alterio C, et al. Among authors: di lorenzo g. Curr Cancer Drug Targets. 2012 Jul;12(6):693-702. doi: 10.2174/156800912801784820. Curr Cancer Drug Targets. 2012. PMID: 22463589
Targeted therapy in the treatment of metastatic renal cell cancer.
Di Lorenzo G, Scagliarini S, Di Napoli M, Scognamiglio F, Rizzo M, Carteni' G. Di Lorenzo G, et al. Among authors: di napoli m. Oncology. 2009;77 Suppl 1:122-31. doi: 10.1159/000258504. Epub 2010 Feb 2. Oncology. 2009. PMID: 20130440 Review.
Is immunotherapy in the future of therapeutic management of sarcomas?
Clemente O, Ottaiano A, Di Lorenzo G, Bracigliano A, Lamia S, Cannella L, Pizzolorusso A, Di Marzo M, Santorsola M, De Chiara A, Fazioli F, Tafuto S. Clemente O, et al. Among authors: di lorenzo g, di marzo m. J Transl Med. 2021 Apr 26;19(1):173. doi: 10.1186/s12967-021-02829-y. J Transl Med. 2021. PMID: 33902630 Free PMC article. Review.
Malignant Sinonasal Tumors: Update on Histological and Clinical Management.
Bracigliano A, Tatangelo F, Perri F, Di Lorenzo G, Tafuto R, Ottaiano A, Clemente O, Barretta ML, Losito NS, Santorsola M, Tafuto S. Bracigliano A, et al. Among authors: di lorenzo g. Curr Oncol. 2021 Jul 1;28(4):2420-2438. doi: 10.3390/curroncol28040222. Curr Oncol. 2021. PMID: 34287240 Free PMC article. Review.
782 results